Brachytherapy is a type of radiotherapy where a radioactive source is placed inside or close to the area that requires treatment. This allows for a high dose of radiation to be delivered to a specific area while minimizing exposure to surrounding healthy tissue. Brachytherapy allows a higher dose of radiation in a smaller area than might be possible with external radiation treatment. It uses a radiation source that’s usually sealed in a small holder called an implant. The increasing prevalence of cancer along with the increasing adoption of early diagnostic procedures attributes to the market growth of the brachytherapy treatment planning systems market. For instance, according to the WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Furthermore, the increasing acceptance of radiation therapy in the treatment of cancer diseases is also a supplementing factor responsible for the growth of the market.
Ask for Sample Customization- https://univdatos.com/get-a-free-sample-form-php/?product_id=35375
The Brachytherapy Treatment Planning Systems Market is expected to grow at a steady rate of around 8% owing to the frequent launches of brachytherapy services. For instance, in June 2022, RaySearch Laboratories AB (publ) announces the launch of RayStation®* 12A, the latest version of the company’s advanced treatment planning system. Version 12A includes innovative new features in addition to several general enhancements.
According to UnivDatos Market Insights (UMI)’ research report “Global Brachytherapy Treatment Planning Systems Market”, the market is expected to witness robust growth during the forecast period (2022-2028). This is mainly due to the high healthcare investment and increasing awareness about cancer and its treatment.
Based on the component, the market has been categorized into auto-contouring software, multi-modality software, PET/CT deformable software, and DICOM-RT software. Among them, the PET/CT deformable software category is to grow at a considerable rate during the forecast period. PET/CT deformable software Brachytherapy Treatment Planning Systems are software programs that integrate images from PET (Positron Emission Tomography) and CT (Computed Tomography) scans to provide accurate 3D models of the treatment area. This software provides a precise and individualized treatment plan, improving the accuracy of the dose delivery and reducing the risk of normal tissue damage. There are several factors that are responsible for the segmental growth of PET/CT deformable software.
For Detailed Analysis on the topic- https://univdatos.com/report/brachytherapy-treatment-planning-systems-market/
Based on the techniques, the market has been categorized into 3D image reconstruction, in-room imaging, and image registration using a graphics processor unit. Among them, the in-room imaging segment held a dominating share of the market in 2021. The in-room imaging In-room imaging allows for real-time verification and adjustments to the treatment plan during the procedure to ensure accurate delivery of the radiation dose. Due to its real-time monitoring and accurate imaging techniques, the segment acquires a prominent share of the market.
North America to witness extensive growth
For a better understanding of the market adoption of the brachytherapy treatment planning systems industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated hold a dominant market share in 2021. This is mainly due to the companies offering a range of brachytherapy treatment planning systems, including software solutions and hardware systems, to meet the diverse needs of healthcare providers and patients. The market is expected to continue growing, driven by factors such as an aging population, increasing incidence of cancer, and advancements in technology.
According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Brachytherapy Treatment Planning Systems market are Abbott; F. Hoffmann-La Roche Ltd; BIOMÉRIEUX; Danaher; Quidel Corporation; QIAGEN; Co-Diagnostics, Inc.; Biocartis; Meridian Bioscience, Inc.; and Thermo Fisher Scientific
“Global Brachytherapy Treatment Planning Systems Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.
Market Segmentation:
1. By Component (Auto-Contouring Software, Multi-Modality Software, PET/CT Deformable Software, and DICOM-RT Software)
2. By Techniques (3D Image Reconstruction, In-Room Imaging, and Image Registration using a Graphics Processor Unit)
3. By Region (North America, Europe, Asia-Pacific, Rest of the World)
4. By Company (Elekta; Varian Medical Systems, Inc.; MIM Software Inc.; RaySearch Laboratories; Prowess Inc.; Concure Oncology; BEBIG Medical GmbH; Sensus Healthcare; Isoray Inc.; and IsoAid)
Key questions answered in the study:
1. What are the current and future trends in the global brachytherapy treatment planning systems industry?
2. How the industry has been evolving in terms of components and techniques?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the global brachytherapy treatment planning systems industry?
5. What is the customer orientation, purchase behavior, and expectations from the global suppliers across various region and countries?
Table of Content:-
1 MARKET INTRODUCTION
2 RESEARCH METHODOLOGY OR ASSUMPTION
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 IMPACT OF COVID-19 ON THE BRACHYTHERAPY TREATMENT PLANNING SYSTEMS MARKET
6 BRACHYTHERAPY TREATMENT PLANNING SYSTEMS MARKET REVENUE (USD BN), 2020-2028F
7 MARKET INSIGHTS BY COMPONENT
8 MARKET INSIGHTS BY TECHNIQUE
9 MARKET INSIGHTS BY REGION
10 BRACHYTHERAPY TREATMENT PLANNING SYSTEMS MARKET DYNAMICS
11 BRACHYTHERAPY TREATMENT PLANNING SYSTEMS MARKET OPPORTUNITIES
12 BRACHYTHERAPY TREATMENT PLANNING SYSTEMS MARKET TRENDS
13 DEMAND AND SUPPLY-SIDE ANALYSIS
14 VALUE CHAIN ANALYSIS
15 COMPETITIVE SCENARIO
16 COMPANY PROFILED
17 DISCLAIMER